“…Multiple mechanisms are known to participate in the regulation of ENaC activity, including limited proteolysis (30,43,44), hormonal mediated effects on translocation and membrane assembly (9,13,45,46), a serum and glucocorticoid-regulated kinase (SGK-1)-mediated phosphorylation of Nedd4 -2 leading to reduced ubiquitination, retrieval and degradation (17,18,47,48), as well as negative and positive hormonal effects mediated by protein kinases including ERK1/2, protein kinases A and C, and phosphatidylinositol 3-kinase, among others (14 -19, 47-49). Added to the above is the present identification of the Cyp2c44 epoxygenase and its EET metabolites as a new class of in vivo regulators of ENaC activity.…”